News CONMED Corporation

Equities

CNMD

US2074101013

Real-time Estimate Cboe BZX Other stock markets 03:43:20 2024-05-10 pm EDT			5-day change	1st Jan Change
71.29 ^USD	+1.35%		-0.60%	-34.86%

Apr. 25	Wells Fargo Adjusts Price Target on CONMED to $77 From $98, Maintains Equalweight Rating	MT
Apr. 25	Needham Lowers Price Target on CONMED to $107 From $129, Notes Slight Guidance Cut Due to Currency, Keeps Buy Rating	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

CONMED Corporation to Present at the BofA Securities Healthcare Conference	May. 01	BU
Wells Fargo Adjusts Price Target on CONMED to $77 From $98, Maintains Equalweight Rating	Apr. 25	MT
Needham Lowers Price Target on CONMED to $107 From $129, Notes Slight Guidance Cut Due to Currency, Keeps Buy Rating	Apr. 25	MT
Transcript : CONMED Corporation, Q1 2024 Earnings Call, Apr 24, 2024	Apr. 24
Conmed: Q1 Earnings Snapshot	Apr. 24	AQ
Earnings Flash (CNMD) CONMED CORPORATION Posts Q1 Revenue $312.3M, vs. Street Est of $306.7M	Apr. 24	MT
CONMED Corporation Promotes Patrick Beyer to Chief Operating Officer	Apr. 24	BU
CONMED Corporation Promotes Patrick Beyer to Chief Operating Officer	Apr. 24	CI
CONMED Corporation Announces First Quarter 2024 Financial Results	Apr. 24	BU
CONMED Corporation Revises Earnings Guidance for the Full Year 2024	Apr. 24	CI
CONMED Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 24	CI
CONMED Corporation Announces Not Stand for Re-Election of Jerome Lande as Director	Apr. 08	CI
CONMED Corporation to Announce First Quarter 2024 Financial Results on April 24, 2024	Apr. 02	BU
Ex-dividend day	Mar. 13	FA
CONMED Corporation Announces Quarterly Cash Dividend	Feb. 27	BU
CONMED Corporation Declares Quarterly Cash Dividend, Payable on April 5, 2024	Feb. 27	CI
Sector Update: Health Care Stocks Rise in Late Afternoon	Feb. 01	MT
CONMED Shares Fall After Q4 Results Trail Analyst Estimates	Feb. 01	MT
Needham Adjusts Price Target on CONMED to $129 From $119, Maintains Buy Rating	Feb. 01	MT
JPMorgan Cuts CONMED Price Target to $115 From $135, Maintains Overweight Rating	Feb. 01	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News CONMED Corporation

Equities

CNMD

US2074101013

Summary

Filters